TWI347183B - 2-(1h-indolylsulfanyl)-benzyl amine derivatives - Google Patents

2-(1h-indolylsulfanyl)-benzyl amine derivatives

Info

Publication number
TWI347183B
TWI347183B TW093139107A TW93139107A TWI347183B TW I347183 B TWI347183 B TW I347183B TW 093139107 A TW093139107 A TW 093139107A TW 93139107 A TW93139107 A TW 93139107A TW I347183 B TWI347183 B TW I347183B
Authority
TW
Taiwan
Prior art keywords
indolylsulfanyl
amine derivatives
benzyl amine
benzyl
derivatives
Prior art date
Application number
TW093139107A
Other languages
English (en)
Other versions
TW200607499A (en
Inventor
Jan Kehler
Karsten Juhl
Jimmy Sejberg
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW200607499A publication Critical patent/TW200607499A/zh
Application granted granted Critical
Publication of TWI347183B publication Critical patent/TWI347183B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW093139107A 2003-12-23 2004-12-16 2-(1h-indolylsulfanyl)-benzyl amine derivatives TWI347183B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200301923 2003-12-23

Publications (2)

Publication Number Publication Date
TW200607499A TW200607499A (en) 2006-03-01
TWI347183B true TWI347183B (en) 2011-08-21

Family

ID=36603121

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093139107A TWI347183B (en) 2003-12-23 2004-12-16 2-(1h-indolylsulfanyl)-benzyl amine derivatives

Country Status (24)

Country Link
EP (1) EP1860100B1 (zh)
KR (2) KR100872022B1 (zh)
CN (2) CN101372474A (zh)
AR (1) AR046978A1 (zh)
AT (1) ATE500220T1 (zh)
CA (1) CA2551168C (zh)
DE (1) DE602004031680D1 (zh)
DK (1) DK1860100T3 (zh)
EA (2) EA012752B1 (zh)
ES (1) ES2362237T3 (zh)
HK (1) HK1103075A1 (zh)
IS (2) IS2551B (zh)
ME (1) ME01040B (zh)
MY (1) MY143038A (zh)
NO (1) NO336676B1 (zh)
NZ (1) NZ547046A (zh)
PL (1) PL1860100T4 (zh)
PT (1) PT1860100E (zh)
RS (1) RS51899B (zh)
SG (1) SG141463A1 (zh)
SI (1) SI1860100T1 (zh)
TW (1) TWI347183B (zh)
UA (1) UA82920C2 (zh)
ZA (1) ZA200705870B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224201B (zh) * 2007-01-18 2011-10-05 和泓生物技术（上海）有限公司 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用
ES2646834T3 (es) * 2010-08-20 2017-12-18 Amira Pharmaceuticals, Inc. Inhibidores de autotaxina y usos de los mismos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4056632A (en) 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
EP0396827A1 (en) 1989-05-09 1990-11-14 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof
GB8912971D0 (en) 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
GB9126311D0 (en) 1991-12-11 1992-02-12 Wellcome Found Substituted diphenylsulfides
CZ293595A3 (cs) 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
PT923548E (pt) * 1996-08-27 2003-06-30 Wyeth Corp 4-aminoetoxi-indolos como agonistas d2 da dopaminae como ligandos da 5ht1a
DE69930381T2 (de) 1999-04-30 2006-12-07 Trustees Of The University Of Pennsylvania Spect abbildungsreagenzien für serotonintransporter
US6410736B1 (en) 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6436938B1 (en) 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression

Also Published As

Publication number Publication date
RS51899B (en) 2012-02-29
IS8467A (is) 2006-05-15
PT1860100E (pt) 2011-05-25
NZ547046A (en) 2010-04-30
EA010666B1 (ru) 2008-10-30
ATE500220T1 (de) 2011-03-15
SI1860100T1 (sl) 2011-06-30
AR046978A1 (es) 2006-01-04
TW200607499A (en) 2006-03-01
EP1860100A2 (en) 2007-11-28
EA200601226A1 (ru) 2006-10-27
DK1860100T3 (da) 2011-06-14
CN100591666C (zh) 2010-02-24
IS8827A (is) 2009-06-05
EA012752B1 (ru) 2009-12-30
PL1860100T4 (pl) 2011-09-30
CA2551168A1 (en) 2005-07-07
EP1860100A3 (en) 2007-12-05
ZA200705870B (en) 2009-09-30
IS2551B (is) 2009-10-15
CN101372474A (zh) 2009-02-25
KR100872022B1 (ko) 2008-12-05
NO20063405L (no) 2006-07-24
HK1103075A1 (en) 2007-12-14
KR20060118529A (ko) 2006-11-23
EP1860100B1 (en) 2011-03-02
KR20080092471A (ko) 2008-10-15
UA82920C2 (en) 2008-05-26
DE602004031680D1 (de) 2011-04-14
SG141463A1 (en) 2008-04-28
CN1898204A (zh) 2007-01-17
CA2551168C (en) 2011-09-13
IS2815B (is) 2012-11-15
NO336676B1 (no) 2015-10-19
ES2362237T3 (es) 2011-06-30
EA200702258A1 (ru) 2008-02-28
ME01040B (me) 2010-05-07
MY143038A (en) 2011-02-28
PL1860100T3 (pl) 2011-07-29

Similar Documents

Publication Publication Date Title
IL204829A0 (en) Aniline derivatives
IL175065A0 (en) Amide derivatives
IL209082A0 (en) Fushed heterocyclic compounds
IL185604A0 (en) Pyrrolo-triazine aniline derivatives
IL211894A0 (en) Amide derivatives
IL183133A0 (en) Dibenzyl amine compounds and derivatives
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
HK1106245A1 (en) Amide derivatives
HK1093061A1 (zh) 氨基鏈烷醇衍生物
EP1689389A4 (en) Indole compounds
EP1652843A4 (en) AMIDE DERIVATIVES
IL188064A0 (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
PL377519A1 (pl) Związki N-(indoloetylo-)cykloaminowe
EP1476425A4 (en) Heterocyclic Aryl Sulphonamidocyclic Compounds
GB0329572D0 (en) Amide derivatives
IL169505A0 (en) Novel anticonvulsant derivatives salts
GB2403474B (en) Amide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
HK1103075A1 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AU2003235889A8 (en) Amide derivatives
EP1538142A4 (en) AMINE DERIVATIVE
ZA200705150B (en) Amide derivatives
ZA200704149B (en) Dibenzyl amine compounds and derivatives
GB0324789D0 (en) Amide derivatives
ZA200507364B (en) Immunomodulating heterocyclic compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees